The Role of Geographic Diversity in Enhancing Supply Chain Resilience and Reducing Risk During Crises

Many healthcare supply chains depend mostly on getting medicines and medical products from just a few places. For example, a 2021 White House report showed that 87% of facilities making active pharmaceutical ingredients (APIs) for generic medicines are outside the U.S., mainly in China and India. Also, 67% of active antimicrobial API Drug Master Files come from these two countries. Having so much makeup in only a few places creates a big risk. If something happens in those areas—like health problems, trade fights, natural disasters, or other issues—the whole supply chain can get disrupted, which can cause shortages of important medicines.

This focus on just a few areas can cause delivery delays and raise costs. This can be hard for healthcare providers who need steady supplies for patients. The COVID-19 pandemic showed how weak these supply chains can be. It exposed problems that people did not expect and made healthcare managers and supply teams in the U.S. rethink how they work.

Multi-Shoring: Spreading Risk Across Regions

To avoid relying on only one place or supplier, the idea of multi-shoring has become popular. Multi-shoring means getting materials and making products in several countries or areas. It includes ways like:

• Onshoring: Making goods inside the U.S.
• Nearshoring: Getting supplies from close countries like Canada or Mexico.
• Friendshoring: Using suppliers in friendly or politically similar countries to balance risks.
• Offshoring: Using foreign suppliers but spreading them across different countries to avoid too much focus on one place.

By spreading out where supplies come from, companies lower the risk that a problem in one region will stop all supplies. For U.S. healthcare, this means having medicines and supplies even if one supply center has problems.

Having many places making drugs is important to stop shortages. Geographic diversity helps lower risks from natural disasters, pandemics, political troubles, and trade problems that can hit one area.

Challenges in Building Geographic Diversity for Medical Supplies

Even though having supplies from many places helps, building that kind of supply chain is not easy. Healthcare groups and their suppliers face several problems:

• Higher Costs: Making products in the U.S. costs about 30 to 50% more than in countries like China, India, or Mexico. This hits generic drug makers harder because their profits are small.
• Regulatory Hurdles: Moving production means following different rules, quality standards, and approval steps, which take time and money.
• Workforce and Infrastructure: U.S. factories need skilled workers and special equipment, which might be limited or expensive in some places.
• Switching Costs: Companies used to one supplier have to make many changes in operations, contracts, and shipping when they switch.

Still, there is unused capacity in U.S. drug manufacturing. About half of U.S. manufacturing space is not in use now. With the right investments in new machines and workforce training, U.S. production could grow to lower reliance on foreign supplies.

The Impact of the COVID-19 Pandemic on Supply Chain Perspective

COVID-19 disruptions made healthcare groups and supply chain workers rethink their sourcing plans. A survey of over 700 supply chain leaders found nearly 90% saw geographic diversity as important to reduce risks. But before the pandemic, only 31% had backup suppliers for 70% or more of their main suppliers.

Also, 94% valued resilient supply chains, but only about two-thirds gave enough funding to build that mindset inside their groups. This shows a gap between knowing what matters and actually spending enough money to improve.

The pandemic caused delays for more than 60% of original equipment makers (OEMs), mainly because supply chains were too focused in few places. In healthcare, delays can harm patient care, especially for people with long-term sickness or emergency needs that require key drugs.

Predictive Risk Management and Technology Investments

The pandemic showed big gaps in predicting supply chain problems. Only 17% of supply chain experts said their risk prediction programs were very good before or early in the pandemic. Predictive risk management uses data, artificial intelligence (AI), and digital tools to guess problems before they happen and plan ahead.

For healthcare supply chains, it means spending on digital systems that warn early about supplier delays, shipping problems, or political issues. These systems help organizations change orders, use backup suppliers, and talk early with shipping companies.

Nearly all surveyed said they are spending more on technology or services to handle pandemic issues. AI-based systems and digital dashboards give real-time views of supply chain status. This helps healthcare IT managers and leaders make fast, smart choices.

Supporting Healthcare Supply Chains with AI and Workflow Automation

Healthcare front office and supply chain work becomes more complex during crises. Companies like Simbo AI, which offer AI-powered phone automation and answering services, play a helpful role in making supply chains work better.

Healthcare managers often spend a lot of time handling supply orders, delivery schedules, and vendor communication. AI answering systems can take care of simple tasks, cut phone wait times, and make sure suppliers and providers get important updates quickly.

Simbo AI’s technology can connect with current IT systems to:

• Automatically send urgent supply calls to the right team.
• Give real-time answers to common supply questions.
• Set follow-up appointments or send automatic shipment updates.

By automating office tasks, healthcare managers and IT staff can focus more on planning supply chains, like choosing multi-shoring or making new supplier deals, not on routine work.

AI can also help predict supply chain risks in healthcare. It does this by looking at past supply data, shipping trends, and outside risks like local COVID-19 outbreaks or political problems. AI can then guess possible issues before they happen.

These predictions help healthcare providers make backup plans, order from different places, or speed up restocking of key supplies before running out. Adding AI and automation to supply chain communications and risk checks helps make supply chains stronger and keeps operations running smoothly.

Cross-Divisional Collaboration and Supply Chain Coordination

Strong healthcare supply chains also need teamwork between different parts of medical groups. Practice managers, buyers, clinical staff, and IT people must work closely to line up supply plans with patient care needs.

Working together helps with:

• Sharing real-time information on supplies and usage.
• Matching buying schedules to patient care forecasts.
• Coordinating with outside partners about shipping changes or supplier problems.

This teamwork reduces waste, stops running out of supplies, and speeds responses during emergencies. Healthcare IT supports this by providing shared systems where all departments see the same supply data and can communicate easily.

Risks of Single-Source and Single-Region Supply Chains to Medical Practices

In U.S. healthcare, relying on one supplier from one region can block access to needed medicines and equipment. Supply outages are more than just annoying—they can delay important medical treatments or harm patient health.

For example, if a practice depends on a generic drug made mostly in one area that faces a natural disaster or export ban, the supply might disappear quickly. Using many locations helps avoid this problem. This means having American factories, nearby countries as partners, or trusted international allies as sources.

Grant Anderson, a well-known supply chain risk expert, says multi-sourcing is a must now, not a choice. Most companies and healthcare providers need backup plans where many suppliers make the same product in different places.

Final Considerations for Healthcare Supply Chain Resilience in the U.S.

Lessons from COVID-19 and other supply chain issues show that geographic diversity is very important to make healthcare supply chains stronger in the U.S. Building a strong supply chain needs more than just adding suppliers; it takes investment in U.S. manufacturing, easier regulations, and new technologies.

Healthcare leaders, like practice managers, owners, and IT experts, play a key role in pushing their supply partners to use multi-shoring strategies and predictive tools. When companies spend enough resources on these, they can lower risks from worldwide problems and keep patient care steady.

By combining geographic diversity with AI and automation, healthcare groups can keep their communication clear, spot supply problems before they start, and react fast in crises. This approach supports medical practices in giving steady, quality care to their communities.

In summary, geographic diversity and technology improvements together build a stronger, more reliable healthcare supply chain in the U.S. This chain can better handle future problems and serve both patients and providers well.